Evercore Wealth Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Evercore Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $247,796 - $285,246	-22,425 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.58 - $14.01 $3,603 - $5,884	-420 Reduced 1.84%	22,425 $226,000
Q4 2019 Feb 13, 2020	BUY	$8.22 - $14.0 $3,452 - $5,880	420 Added 1.87%	22,845 $304,000
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $270,669 - $333,459	22,425	22,425 $354,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evercore Wealth Management, LLC with notifications on news.